Pramlintide
TOTT
AstraZeneca · Phase 2/3 · Withdrawn · Enrollment 0
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Pramlintide
AstraZeneca · Phase 2/3 · Withdrawn · Enrollment 0
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.